non-Hodgkin’s lymphomaDiffuse large B-cell lymphoma (DLBCL)DLBCLCD20 immunotherapy
…use large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin’s lymphoma. Although standard immunochemotherapy is available, 30%–40% of …
5articles mentioning diseases
5disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: Diffuse large B-cell lymphoma (DLBCL) ×
Diffuse large B-cell lymphoma (DLBCL)
This disease is selected. Its supporting articles are shown below.
Articles mentioning Diffuse large B-cell lymphoma (DLBCL)
5 articles · page 1 of 1diffuse large B-cell lymphoma (DLBCL)DLBCLrituximabvincristinecyclophosphamideprednisonedoxorubicintetrahydropyranyl-adriamycinfirst-line chemotherapy
…e retrospective study included 108 patients aged ≥70 years with diffuse large B-cell lymphoma (DLBCL) who completed first-line rituximab, cyclophosphamide, doxorubic…
Diffuse large B-cell lymphoma (DLBCL)DLBCLnon-Hodgkin lymphomasaxi-celAxicabtagene ciloleucelsiltuximabdexamethasonemethylprednisoloneanakinratocilizumab
…Background and Importance Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoproliferative neoplasm among non-Hodgk…
Diffuse large B-cell lymphoma (DLBCL)non-Hodgkin lymphomasDLBCLAxi-celaxicabtagene ciloleucel
…Background and Importance Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoproliferative neoplasm among non-Hodgk…
B-cell non-Hodgkin lymphomaB-cell acute lymphoblastic leukemiaB-cell NHLdiffuse large B-cell lymphoma (DLBCL)gemtuzumab ozogamicinInotuzumab ozogamicinAZD2014Kobe Universitygemtuzumab ozogamicin-inducedIO
…nhanced by the combination of the mTORC1/2 inhibitor AZD2014 in B-cell non-Hodgkin lymphoma (B-cell NHL) cell linesAbstract 689 Figure 2AZD2014, alone or i…